Edge Therapeutics (EDGE) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Edge Therapeutics (EDGE) Tops Q4 EPS by 2c

Edge Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results

March 8, 2016 7:00 AM EST

BERKELEY HEIGHTS, N.J., March 08, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the management of acute, life threatening conditions, today announced financial results and corporate highlights for the fourth quarter and full-year ended December 31, 2015.

2015 was a transformative year for Edge, said Brian A. Leuthner, Edges President and Chief Executive Officer.  We completed our Phase 1/2 NEWTON study with our lead program EG-1962, which met all primary and secondary endpoints and showed favorable outcome data. In addition, we raised net proceeds... More